Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HPTN 076 - Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278 LA, for Pre-Exposure Prophylaxis (PrEP)

NCT02165202 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02165202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02165202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HPTN 076 - Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278 LA, for Pre-Exposure Prophylaxis (PrEP)
Lead sponsor
PATH
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
March 9, 2017
Enrollment
136 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus (hiv)